MeSH tree: C14.280.238.625
Research shows that the risk of developing heart conditions after a messenger RNA COVID vaccine is very low, and should not call into question the value of life-saving vaccination campaigns rolled out across the world.
Jul 22, 2022
2
57
The U.S. Centers for Disease Control and Prevention on Tuesday gave its blessing for the emergency use of Novavax's COVID-19 vaccine, the fourth coronavirus shot to be approved in the United States.
Jul 20, 2022
0
34
U.S. adults who haven't gotten any COVID-19 shots yet should consider a new option from Novavax—a more traditional kind of vaccine, influential government advisers said Tuesday.
Jul 19, 2022
0
34
COVID vaccines for children as young as six months look set to be available in the coming months, now the Therapeutic Goods Administration has approved the Moderna vaccine for babies and young children.
Jul 19, 2022
0
50
The U.S. is getting another COVID-19 vaccine choice as the Food and Drug Administration on Wednesday cleared Novavax shots for adults.
Jul 14, 2022
0
93
A study published by The BMJ today provides an up-to-date summary of evidence on the risk of heart inflammation (myocarditis and pericarditis) after mRNA vaccination against the COVID-19 virus.
Jul 13, 2022
0
921
Among children aged 5 to 11 years, most reported adverse events to BNT162b2 COVID-19 vaccination are mild-to-moderate, with few reports of myocarditis, according to a study recently published in Pediatrics.
Jul 11, 2022
0
43
Researchers at the University of São Paulo (USP) in Brazil analyzed data from 43 scientific articles describing the effects of COVID-19 on athletes and concluded that while the disease was asymptomatic or mild in the vast ...
Jul 8, 2022
0
215
